Segui questo link per vedere altri tipi di pubblicazioni sul tema: AIDS dementia complex - Pathogenesis.

Articoli di riviste sul tema "AIDS dementia complex - Pathogenesis"

Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili

Scegli il tipo di fonte:

Vedi i top-50 articoli di riviste per l'attività di ricerca sul tema "AIDS dementia complex - Pathogenesis".

Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.

Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.

Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.

1

Dal Canto, M. C. "AIDS-Dementia-Complex: pathology, pathogenesis and future directions". Italian Journal of Neurological Sciences 10, n. 3 (giugno 1989): 277–87. http://dx.doi.org/10.1007/bf02333773.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
2

Berman, N. E. J., J. K. Johnson, L. Raymond, E. B. Stephens, S. Joag e O. Narayan. "Pathogenesis of the aids dementia complex in the SIV model". European Neuropsychopharmacology 6 (giugno 1996): 22. http://dx.doi.org/10.1016/0924-977x(96)87400-1.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
3

McCaddon, A., B. Regland e C. F. Fear. "Trypsin inhibition: A potential cause of cobalamin deficiency common to the pathogenesis of Alzheimer-type dementia and AIDS dementia complex?" Medical Hypotheses 45, n. 2 (agosto 1995): 200–204. http://dx.doi.org/10.1016/0306-9877(95)90069-1.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
4

Krivine, Anne, Gilles Force, Jerome Servan, Anne-Elisabeth Cabée, Flore Rozenberg, Lucia Dighiero, Françoise Marguet e Pierre Lebon. "Measuring HIV-1 RNA and interferon-α in the cerebrospinal fluid of AIDS patients: insights into the pathogenesis of AIDS Dementia Complex". Journal of Neurovirology 5, n. 5 (gennaio 1999): 500–506. http://dx.doi.org/10.3109/13550289909045379.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
5

Cunningham, A. L., H. Naif, N. Saksena, G. Lynch, J. Chang, S. Li, R. Jozwiak et al. "HIV infection of macrophages and pathogenesis of AIDS dementia complex: interaction of the host cell and viral genotype". Journal of Leukocyte Biology 62, n. 1 (luglio 1997): 117–25. http://dx.doi.org/10.1002/jlb.62.1.117.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
6

Perrella, O., M. Guerriero, E. Izzo, M. Soscia e P. B. Carrieri. "Interleukin-6 and granulocyte macrophage-csf in the cerebrospinal fluid from hiv infected subjects with involvement of the central nervous system". Arquivos de Neuro-Psiquiatria 50, n. 2 (giugno 1992): 180–82. http://dx.doi.org/10.1590/s0004-282x1992000200008.

Testo completo
Abstract (sommario):
We detected the cytokines interleukin-6 (IL-6) and granulocyte macrophage-CSF (GM-CSF) by ELISA in the CSF and serum of 30 HIV-infected patients classified as AIDS dementia complex (ADC), and 20 subjects with other neurological diseases (OND). We have found a high incidence of detectable IL-6 and GM-CSF in the CSF of ADC patients compared with OND patients. No statistical differences were observed between both groups for serum IL-6 and GM-CSF levels. These results suggest an intrathecal synthesis of these cytokines and a possible involvement in the pathogenesis of ADC.
Gli stili APA, Harvard, Vancouver, ISO e altri
7

Price, Richard W. "The AIDS dementia complex as a model for other neurodegenerative diseases: a pathogenetic conceit". Journal of the Neurological Sciences 127, n. 1 (dicembre 1994): 6–7. http://dx.doi.org/10.1016/0022-510x(94)90120-1.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
8

A.L. Sidelkovsky, P.A. Fedorov, V.V. Marusichenko e M.R. Ignatischev. "Damage to the nervous system associated with HIV infection (a clinical case)". INTERNATIONAL NEUROLOGICAL JOURNAL 16, n. 8 (10 marzo 2021): 53–56. http://dx.doi.org/10.22141/2224-0713.16.8.2020.221963.

Testo completo
Abstract (sommario):
In Eastern Europe, at least 130 thousand new cases of HIV infection have been registered, which undoubtedly reflects the urgency of this medical problem. In our country, the average rate of human immunodeficiency infection is 58 cases per 100 thousand people. It is known that the disease is caused by an RNA-containing human immunodeficiency virus. Two types of it have been studied — HIV-1 and HIV-2, which have many subtypes. An important clinical feature of this virus is its tropism to cells of the human nervous and immune systems. The main risk group for the disease is injecting drug users, blood recipients, and people with low social responsibility. The impairment of the nervous system in AIDS is represented by the AIDS-dementia complex, acute aseptic meningitis, HIV-associated myelopathy, pathology of the peripheral nervous system, as well as the influence of opportunistic infections and neoplasms. This article presents a clinical case of lesions of the nervous system associated with HIV infection and also considers the etiology, pathogenesis, features of the course, diagnosis, and treatment of patients with neuro-AIDS.
Gli stili APA, Harvard, Vancouver, ISO e altri
9

Lim, Chai K., Bruce J. Brew, Gayathri Sundaram e Gilles J. Guillemin. "Understanding the Roles of the Kynurenine Pathway in Multiple Sclerosis Progression". International Journal of Tryptophan Research 3 (gennaio 2010): IJTR.S4294. http://dx.doi.org/10.4137/ijtr.s4294.

Testo completo
Abstract (sommario):
The kynurenine pathway (KP) is a major degradative pathway of tryptophan ultimately leading to the production of nicotinamide adenine dinucleotide (NAD+) and is also one of the major regulatory mechanisms of the immune response. The KP is known to be involved in several neuroinflammatory disorders including Alzheimer's disease, amyotrophic lateral sclerosis, AIDS dementia complex, Parkinson's disease, schizophrenia, Huntington's disease and brain tumours. However, the KP remains a relatively new topic for the field of multiple sclerosis (MS). Over the last 2–3 years, some evidence has progressively emerged suggesting that the KP is likely to be involved in the pathogenesis of autoimmune diseases especially MS. Some KP modulators are already in clinical trials for other inflammatory diseases and would potentially provide a new and important therapeutic strategy for MS patients. This review summarizes the known relationships between the KP and MS.
Gli stili APA, Harvard, Vancouver, ISO e altri
10

Talley, A. K., S. Dewhurst, S. W. Perry, S. C. Dollard, S. Gummuluru, S. M. Fine, D. New, L. G. Epstein, H. E. Gendelman e H. A. Gelbard. "Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA." Molecular and Cellular Biology 15, n. 5 (maggio 1995): 2359–66. http://dx.doi.org/10.1128/mcb.15.5.2359.

Testo completo
Abstract (sommario):
Tumor necrosis factor alpha (TNF-alpha) is a candidate human immunodeficiency virus type 1-induced neurotoxin that contributes to the pathogenesis of AIDS dementia complex. We report here on the effects of exogenous TNF-alpha on SK-N-MC human neuroblastoma cells differentiated to a neuronal phenotype with retinoic acid, TNF-alpha caused a dose-dependent loss of viability and a corresponding increase in apoptosis in differentiated SK-N-MC cells but not in undifferentiated cultures. Importantly, intracellular signalling via TNF receptors, as measured by activation of the transcription factor NF-kappa B, was unaltered by retinoic acid treatment. Finally, overexpression of bcl-2 or crmA conferred resistance to apoptosis mediated by TNF-alpha, as did the addition of the antioxidant N-acetylcysteine. These results suggest that TNF-alpha induces apoptosis in neuronal cells by a pathway that involves formation of reactive oxygen intermediates and which can be blocked by specific genetic interventions.
Gli stili APA, Harvard, Vancouver, ISO e altri
11

Portegies, Peter, e Nathalie R. Rosenberg. "AIDS Dementia Complex". CNS Drugs 9, n. 1 (1998): 31–40. http://dx.doi.org/10.2165/00023210-199809010-00004.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
12

DeArmond, S. J. "Aids Dementia Complex". Microscopy and Microanalysis 5, S2 (agosto 1999): 1090–91. http://dx.doi.org/10.1017/s1431927600018778.

Testo completo
Abstract (sommario):
The World Health Organization estimates by the year 2000 that the cumulative total of HIV-1 infected adults and children will be about 30 million worldwide. Disease of the central nervous system (CNS) in association with AIDS is common. 20-30% of AIDS patients will develop varying degrees of cognitive and motor deficits designated the “AIDS dementia Complex (ADC)” or “HIV-1-associated cognitive/motor deficit”. Progression of symptoms is usually slow and irregular. In the end-stage, the patient is severely impaired with mutism, incontinence and prominent motor impairment. Neuroradiologic studies show generalized cortical atrophy and diffuse white matter changes. HIV can be cultured from the CSF. Neurologic involvement in pediatric AIDS is very common with CNS complications usually occurring within the first two postnatal years. Given the severeness of the dementia and motor dysfunction in ADC, one is struck by the paucity of neuropathological features. Hematoxylin and eosin stained sections reveal only three neuropathological features. First, there are small numbers of microglial nodules scattered in the white matter and sometimes in grey matter (Fig. 1). However, microglial nodules occur in virtually all viral infections of the CNS, including CMV micronodular encephalitis in AIDS patients.
Gli stili APA, Harvard, Vancouver, ISO e altri
13

Katz, Anne. "AIDS Dementia Complex". Journal of Palliative Care 10, n. 1 (marzo 1994): 46–50. http://dx.doi.org/10.1177/082585979401000112.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
14

Brew, Bruce James. "AIDS DEMENTIA COMPLEX". Neurologic Clinics 17, n. 4 (novembre 1999): 861–81. http://dx.doi.org/10.1016/s0733-8619(05)70170-5.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
15

Prockop, Leon D. "AIDS dementia complex". Journal of Legal Medicine 9, n. 4 (dicembre 1988): 509–17. http://dx.doi.org/10.1080/01947648809513542.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
16

Wilson, Susan E. "AIDS Dementia Complex". AIDS Patient Care 3, n. 5 (ottobre 1989): 20–22. http://dx.doi.org/10.1089/apc.1989.3.20.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
17

Weisberg, Leon A., e Web Ross. "AIDS dementia complex". Postgraduate Medicine 86, n. 1 (luglio 1989): 213–20. http://dx.doi.org/10.1080/00325481.1989.11704337.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
18

Vinters, Harry V. "The AIDS dementia complex". Annals of Neurology 21, n. 6 (giugno 1987): 612. http://dx.doi.org/10.1002/ana.410210618.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
19

Price, R. W., e B. J. Brew. "The AIDS Dementia Complex". Journal of Infectious Diseases 158, n. 5 (1 novembre 1988): 1079–83. http://dx.doi.org/10.1093/infdis/158.5.1079.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
20

Wu, Yun-Cheng, Yong-Bo Zhao, Meng-Guang Tang, Sandy Xinyu Zhang-Nunes e Justin C. McArthur. "AIDS dementia complex in China". Journal of Clinical Neuroscience 14, n. 1 (gennaio 2007): 8–11. http://dx.doi.org/10.1016/j.jocn.2005.07.012.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
21

Portegies, Peter, RoelienH Enting, MennoD de Jong, SvenA Danner, Peter Reiss, Jaap Goudsmit e JoepMA Lange. "AIDS dementia complex and didanosine". Lancet 344, n. 8924 (settembre 1994): 759. http://dx.doi.org/10.1016/s0140-6736(94)92252-7.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
22

Perrella, Oreste, Alessandro Perrella, Marco Perrella, Costanza Sbreglia e Gugliemo Borgia. "Cytokines and AIDS dementia complex". AIDS 17, n. 1 (gennaio 2003): 134–36. http://dx.doi.org/10.1097/00002030-200301030-00022.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
23

Morriss, R., e A. House. "Zidovudine in AIDS dementia complex." BMJ 299, n. 6709 (11 novembre 1989): 1218. http://dx.doi.org/10.1136/bmj.299.6709.1218-a.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
24

Baert, A. E. "Neuropathology of Aids and the Aids-dementia complex". Clinical Neurology and Neurosurgery 91, n. 4 (gennaio 1989): 370. http://dx.doi.org/10.1016/0303-8467(89)90043-7.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
25

Buhrich, Neil. "HIV, Psychosis and AIDS Dementia Complex". Australasian Psychiatry 3, n. 4 (agosto 1995): 238–39. http://dx.doi.org/10.3109/10398569509080418.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
26

Buckingham, Stephan L., e Wilfred G. Van Gorp. "AIDS-Dementia Complex: Implications for Practice". Social Casework 69, n. 6 (giugno 1988): 371–75. http://dx.doi.org/10.1177/104438948806900608.

Testo completo
Abstract (sommario):
AIDS and the dementia associated with it have created new challenges for social workers. The authors identify unique issues around the AIDS-dementia complex. Implications for social work practice are discussed, and recommendations for assisting the growing population with this complex are made.
Gli stili APA, Harvard, Vancouver, ISO e altri
27

Navia, Bradford A., Eun-Sook Cho, Carol K. Petito e Richard W. Price. "The AIDS dementia complex: II. Neuropathology". Annals of Neurology 19, n. 6 (giugno 1986): 525–35. http://dx.doi.org/10.1002/ana.410190603.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
28

Maher, John, Rshujeel Choudhri, William Halliday, Christopher Power e Avindra Nath. "AIDS dementia complex with generalized myoclonus". Movement Disorders 12, n. 4 (luglio 1997): 593–97. http://dx.doi.org/10.1002/mds.870120418.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
29

SCHARNHORST, SUSANNE. "AIDS Dementia Complex in the Elderly". Nurse Practitioner 17, n. 8 (agosto 1992): 37,41–43. http://dx.doi.org/10.1097/00006205-199208000-00015.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
30

Patton, Holly K., Etty Benveniste e Dale J. Benos. "Astrocytes and the AIDS Dementia Complex". Journal of Neuro-AIDS 1, n. 1 (12 ottobre 1995): 111–31. http://dx.doi.org/10.1300/j128v01n01_06.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
31

Meehan, Rebecca A., e Jennifer A. Brush. "An overview of AIDS dementia complex". American Journal of Alzheimer's Disease & Other Dementiasr 16, n. 4 (luglio 2001): 225–29. http://dx.doi.org/10.1177/153331750101600411.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
32

Katz, Anne. "Delayed Diagnosis of AIDS Dementia Complex". AIDS Patient Care 8, n. 4 (agosto 1994): 183–84. http://dx.doi.org/10.1089/apc.1994.8.183.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
33

Verma, R. C., L. R. Bennett, M. P. Can, G. Mathiesen, F. Kiouraehr, W. Riege, C. Wasterlain e F. D. Jones. "NONINVASIVE EVALUATION OF AIDS DEMENTIA COMPLEX". Clinical Nuclear Medicine 14, Supplement (settembre 1989): P12. http://dx.doi.org/10.1097/00003072-198909001-00013.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
34

Price, Richard W. "The AIDS dementia complex: Current status". Journal of Neuroimmunology 16, n. 1 (settembre 1987): 4. http://dx.doi.org/10.1016/0165-5728(87)90136-6.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
35

Ho, David D. "The Acquired Immunodeficiency Syndrome (AIDS) Dementia Complex". Annals of Internal Medicine 111, n. 5 (1 settembre 1989): 400. http://dx.doi.org/10.7326/0003-4819-111-5-400.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
36

Price, Richard W., John Sidtis e Marc Rosenblum. "The aids dementia complex: Some current questions". Annals of Neurology 23, S1 (1988): S27—S33. http://dx.doi.org/10.1002/ana.410230711.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
37

Navia, Bradford A., Barry D. Jordan e Richard W. Price. "The AIDS dementia complex: I. Clinical features". Annals of Neurology 19, n. 6 (giugno 1986): 517–24. http://dx.doi.org/10.1002/ana.410190602.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
38

von Einsiedel, R. Grafin, E. Minami, D. L. Secor, S. Pang, I. S. Y. Chen e H. V. Vinters. "STRUCTURAL COMPONENTS OF THE AIDS DEMENTIA COMPLEX". Journal of Neuropathology and Experimental Neurology 49, n. 3 (maggio 1990): 351. http://dx.doi.org/10.1097/00005072-199005000-00277.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
39

Portegies, Peter, Roelien H. Enting, Jan de Gans, Paul R. Algra, Mayke M. A. Derix, Joep M. A. Lange e Jaap Goudsmit. "Presentation and course of AIDS dementia complex". AIDS 7, n. 5 (maggio 1993): 669–76. http://dx.doi.org/10.1097/00002030-199305000-00010.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
40

Tross, Susan, Richard W. Price, Bradford Navia, Howard T. Thaler, Jonathan Gold, Dan Alan Hirsch e John J. Sidtis. "Neuropsychological characterization of the AIDS dementia complex". AIDS 2, n. 2 (aprile 1988): 81–88. http://dx.doi.org/10.1097/00002030-198804000-00002.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
41

Chiesi, A., S. Vella, L. G. Dally, C. Pedersen, S. Danner, A. M. Johnson, S. Schwander, F. D. Goebel, M. Glauser e F. Antunes. "Epidemiology of AIDS Dementia Complex in Europe". Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 11, n. 1 (gennaio 1996): 39–44. http://dx.doi.org/10.1097/00042560-199601010-00005.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
42

Schutzer, Steven E. "234 Autoimmune role in AIDS dementia complex". Journal of Allergy and Clinical Immunology 81, n. 1 (gennaio 1988): 227. http://dx.doi.org/10.1016/0091-6749(88)90469-1.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
43

Fiala, Milan, Elyse J. Singer, Michael C. Graves, Wallace W. Tourtellotte, John A. Stewart, Charles A. Schable, Roy H. Rhodes e Harry V. Vinters. "AIDS dementia complex complicated by cytomegalovirus encephalopathy". Journal of Neurology 240, n. 4 (1993): 223–31. http://dx.doi.org/10.1007/bf00818709.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
44

Estep, G. "The aids dementia complex: I. Clinical features". Journal of Emergency Medicine 5, n. 2 (gennaio 1987): 166. http://dx.doi.org/10.1016/0736-4679(87)90098-9.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
45

Jubelt, Burk. "Abacavir for treatment of AIDS dementia complex". Current Neurology and Neuroscience Reports 1, n. 6 (novembre 2001): 516–17. http://dx.doi.org/10.1007/s11910-001-0055-1.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
46

Kim, Dennis M., Robert Tien, Christopher Byrum e K. Ranga Rama Krishnan. "Imaging in acquired immune deficiency syndrome dementia complex (AIDS dementia complex): A review". Progress in Neuro-Psychopharmacology and Biological Psychiatry 20, n. 3 (aprile 1996): 349–70. http://dx.doi.org/10.1016/0278-5846(96)00002-4.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
47

Power, Christopher, e Richard T. Johnson. "HIV-1 Associated Dementia: Clinical Features and Pathogenesis". Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 22, n. 2 (maggio 1995): 92–100. http://dx.doi.org/10.1017/s0317167100040154.

Testo completo
Abstract (sommario):
AbstractHIV-1 infection is characterized by multiple neurological syndromes occuring at all stages of infection. HIV-1-associated dementia, however, is the most devastating CNS consequence of AIDS because of its poor prognosis and functional impairment. A clinical triad of progressive cognitive decline, motor dysfunction, and behavioural abnormalities typifies this subcortical dementia which eventually affects 15 to 20% of AIDS patients. Neuroimaging, CSF studies and neuropsychological testing are frequently required in diagnosing HIV-associated dementia, to exclude other conditions including psychiatric illnesses, opportunistic diseases and systemic disorders. The pathogenesis of HIV dementia is uncertain and there is evidence that multiple mechanisms of neurological injury occur. These mechanisms include: the role of neurovirulent strains of HIV; the potential neurotoxicity of HIV gp120, nitric oxide and quinolinic acid; immunologically mediated CNS injury through the action of cytokines and arachidonic acid metabolites; and altered blood-brain barrier permeability. A collective approach involving clinical studies,in vitroassays and animal models will provide greater insight into the pathogenesis and the rational development of therapy for HIV dementia.
Gli stili APA, Harvard, Vancouver, ISO e altri
48

&NA;. "Zidovudine may delay onset of AIDS dementia complex". Inpharma Weekly &NA;, n. 1022 (febbraio 1996): 16. http://dx.doi.org/10.2165/00128413-199610220-00031.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
49

Brew, Bruce J. "HAART in AIDS dementia complex and palliative care". Progress in Palliative Care 12, n. 4 (agosto 2004): 171–77. http://dx.doi.org/10.1179/096992604225006370.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
50

Rottenberg, D. A., J. R. Moeller, S. C. Strother, J. J. Sidtis, B. A. Navia, V. Dhawan, J. Z. Ginos e R. W. Price. "The metabolic pathology of the AIDS dementia complex". Annals of Neurology 22, n. 6 (dicembre 1987): 700–706. http://dx.doi.org/10.1002/ana.410220605.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
Offriamo sconti su tutti i piani premium per gli autori le cui opere sono incluse in raccolte letterarie tematiche. Contattaci per ottenere un codice promozionale unico!

Vai alla bibliografia